ENTITY

Symbio Pharmaceuticals (4582 JP)

43
Analysis
Health Care • Japan
Symbio Pharmaceuticals Limited develops and commercializes prescription drugs n oncology, hematology and auto-immune disease for Japan and other Asia Pacific markets.
more
•07 Feb 2025 10:00•Issuer-paid

Symbio Pharmaceuticals (4582 JP): Full-year FY12/24 flash update

Sales decreased by 56.1% YoY to JPY2.5bn, with a gross profit of JPY1.9bn and a gross margin of 76.4%. Operating loss increased to JPY3.9bn in...

Logo
203 Views
Share
•31 Oct 2024 20:00•Issuer-paid

Symbio Pharmaceuticals (4582 JP): Q3 FY12/24 flash update

Sales decreased by 57.1% YoY to JPY1.9bn, with operating, recurring, and net losses each at JPY2.8bn. SG&A expenses increased by 12.7% YoY to...

Logo
242 Views
Share
•02 Aug 2024 08:00•Issuer-paid

Symbio Pharmaceuticals (4582 JP): 1H FY12/24 flash update

Sales decreased by 59.6% YoY to JPY1.3bn, with a gross profit of JPY996mn and a gross profit margin of 77.6%. Operating loss was JPY1.7bn,...

Logo
207 Views
Share
•29 Apr 2022 23:25•Issuer-paid

SymBio Pharmaceuticals - Termination of coverage

Edison Investment Research is terminating coverage on Brooge Energy (BROG), Tyman (TYMN), SymBio Pharmaceuticals (4582), Aspire Global (0EAZ),...

Share
•21 Jun 2021 17:43

Asia Shorts: Geely, Ganfeng, Pharmaron, Evergrande, Fujitsu, Canon, Renesas, Toshiba, LGD, Doosan

The Insight looks at large short interest movements across HK, Japan, Korea and Taiwan stocks and highlights large increases/decreases in shorts to...

Logo
345 Views
Share
x